Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways - PubMed (original) (raw)
Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways
Joan C Smith et al. J Invest Dermatol. 2008 May.
Abstract
Keloids are benign tumors of the dermis that form during a protracted wound healing process. Susceptibility to keloid formation occurs predominantly in people of African and Asian descent. The key alteration(s) responsible for keloid formation has not been identified and there is no satisfactory treatment for this disorder. The altered regulatory mechanism is limited to dermal wound healing, although several diseases characterized by an exaggerated response to injury are prevalent in individuals of African ancestry. We have observed a complex pattern of phenotypic differences in keloid fibroblasts grown in standard culture medium or induced by hydrocortisone (HC). In this study Affymetrix-based microarray was performed on RNA obtained from fibroblasts cultured from normal scars and keloids grown in the absence and presence of HC. We observed differential regulation of approximately 500 genes of the 38,000 represented on the Affymetrix chip. Of particular interest was increased expression of several IGF-binding and IGF-binding-related proteins and decreased expression of a subset of Wnt pathway inhibitors and multiple IL-1-inducible genes. Increased expression of connective tissue growth factor and insulin-like growth factor binding protein-3 was observed in keloid fibroblasts only in the presence of HC. These findings support a role for multiple fibrosis-related pathways in the pathogenesis of keloids.
Conflict of interest statement
CONFLICT OF INTEREST
The authors declare no conflict of interest.
Figures
Figure 1
Unsupervised hierarchical clustering was performed on 19 samples of normal and keloid fibroblasts grown with and without hydrocortisone, using a subset of genes (n = 7303) whose expression varied by at least two-fold relative to the average normal strain in at least two of the 19 samples. Gene expression of cell strains grown in medium with and without (control) 1.5 μM hydrocortisone supplementation fell into four distinguishable groups relative to gene expression in the average normal strain grown in control medium. From right to left are 5 normal strains in control medium, 4 normal strains with hydrocortisone (one strain lost in processing), 5 keloid strains in control medium, five keloid strains with hydrocortisone. Red indicates increased expression, blue indicates reduced expression, and yellow indicates no difference in expression.
Similar articles
- Epigenetically altered wound healing in keloid fibroblasts.
Russell SB, Russell JD, Trupin KM, Gayden AE, Opalenik SR, Nanney LB, Broquist AH, Raju L, Williams SM. Russell SB, et al. J Invest Dermatol. 2010 Oct;130(10):2489-96. doi: 10.1038/jid.2010.162. Epub 2010 Jun 17. J Invest Dermatol. 2010. PMID: 20555348 Free PMC article. - Gene expression patterns in isolated keloid fibroblasts.
Satish L, Lyons-Weiler J, Hebda PA, Wells A. Satish L, et al. Wound Repair Regen. 2006 Jul-Aug;14(4):463-70. doi: 10.1111/j.1743-6109.2006.00135.x. Wound Repair Regen. 2006. PMID: 16939575 - Tacrolimus fails to regulate collagen expression in dermal fibroblasts.
Wong VW, You F, Januszyk M, Kuang AA. Wong VW, et al. J Surg Res. 2013 Sep;184(1):678-90. doi: 10.1016/j.jss.2013.04.006. Epub 2013 Apr 25. J Surg Res. 2013. PMID: 23647800 - microRNA deregulation in keloids: an opportunity for clinical intervention?
Yu X, Li Z, Chan MT, Wu WK. Yu X, et al. Cell Prolif. 2015 Dec;48(6):626-30. doi: 10.1111/cpr.12225. Epub 2015 Oct 21. Cell Prolif. 2015. PMID: 26486103 Free PMC article. Review. - Elevated vascular endothelial growth factor in keloids: relevance to tissue fibrosis.
Le AD, Zhang Q, Wu Y, Messadi DV, Akhondzadeh A, Nguyen AL, Aghaloo TL, Kelly AP, Bertolami CN. Le AD, et al. Cells Tissues Organs. 2004;176(1-3):87-94. doi: 10.1159/000075030. Cells Tissues Organs. 2004. PMID: 14745238 Review.
Cited by
- CTHRC1+ fibroblasts are stimulated by macrophage-secreted SPP1 to induce excessive collagen deposition in keloids.
Liu J, Huang Y, Gong Y, Liu Q, Lin J, Liu J, Liu M, Huang J, Pu W, Ma Y, Zhang Y, Li H, Shi X, Zhang Y, Wang J, Zhu Y, Wang Q, Wei K, Wang J, Sha Y, Wang J, Wu W. Liu J, et al. Clin Transl Med. 2022 Dec;12(12):e1115. doi: 10.1002/ctm2.1115. Clin Transl Med. 2022. PMID: 36480415 Free PMC article. No abstract available. - A Placebo-controlled Study of PF-06473871 (Anti-Connective Tissue Growth Factor Antisense Oligonucleotide) in Reducing Hypertrophic Skin Scarring.
Gale JD, Jensen J, Berman G, Freimuth W, Li G, Pleil A, Kutty M, Rosenthal A, Boswell CB, Noah VEM, Young L. Gale JD, et al. Plast Reconstr Surg Glob Open. 2018 Sep 6;6(9):e1861. doi: 10.1097/GOX.0000000000001861. eCollection 2018 Sep. Plast Reconstr Surg Glob Open. 2018. PMID: 30349773 Free PMC article. - Models of abnormal scarring.
Seo BF, Lee JY, Jung SN. Seo BF, et al. Biomed Res Int. 2013;2013:423147. doi: 10.1155/2013/423147. Epub 2013 Sep 3. Biomed Res Int. 2013. PMID: 24078916 Free PMC article. - Activin-mediated alterations of the fibroblast transcriptome and matrisome control the biomechanical properties of skin wounds.
Wietecha MS, Pensalfini M, Cangkrama M, Müller B, Jin J, Brinckmann J, Mazza E, Werner S. Wietecha MS, et al. Nat Commun. 2020 May 25;11(1):2604. doi: 10.1038/s41467-020-16409-z. Nat Commun. 2020. PMID: 32451392 Free PMC article. - Skin regeneration with all accessory organs following ablation with irreversible electroporation.
Golberg A, Villiger M, Felix Broelsch G, Quinn KP, Albadawi H, Khan S, Watkins MT, Georgakoudi I, Austen WG Jr, Bei M, Bouma BE, Mihm MC Jr, Yarmush ML. Golberg A, et al. J Tissue Eng Regen Med. 2018 Jan;12(1):98-113. doi: 10.1002/term.2374. Epub 2017 May 23. J Tissue Eng Regen Med. 2018. PMID: 27976527 Free PMC article.
References
- Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, et al. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene. 2006;25:4116–4121. - PubMed
- August P, Suthanthiran M. Transforming growth factor beta and progression of renal disease. Kidney Int Suppl. 2003:S99–104. - PubMed
- Aune TM, Maas K, Moore JH, Olsen NJ. Gene expression profiles in human autoimmune disease. Curr Pharm Des. 2003;9:1905–1917. - PubMed
- Aune TM, Parker JS, Maas K, Liu Z, Olsen NJ, Moore JH. Co-localization of differentially expressed genes and shared susceptibility loci in human autoimmunity. Genet Epidemiol. 2004;27:162–172. - PubMed
- Barrett J. Keloid. In: Bergsma D, editor. Birth Defect Compendium. Baltimore: Williams and Wilkens Company; 1973. p. 553.
Publication types
MeSH terms
Grants and funding
- F33AR052241/AR/NIAMS NIH HHS/United States
- R03AR048938/AR/NIAMS NIH HHS/United States
- P50 DE010595-08/DE/NIDCR NIH HHS/United States
- F33 AR052241-01/AR/NIAMS NIH HHS/United States
- R03 AR048938-01/AR/NIAMS NIH HHS/United States
- R03 AR048938/AR/NIAMS NIH HHS/United States
- P30 AR041943/AR/NIAMS NIH HHS/United States
- F33 AR052241/AR/NIAMS NIH HHS/United States
- P50DE10595/DE/NIDCR NIH HHS/United States
- P30AR041943/AR/NIAMS NIH HHS/United States
- P30 AR041943-100031/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases